CNSY

0.630110.29%
HC

Howard Clowes

Independent Director

Mr. Howard Clowes serves as an Independent Director of Cerenome, Inc. (formerly known as Plus Therapeutics, Inc.), since April 1, 2020. Since January 2005 until he retired as a lawyer in December 2018, Mr. Clowes was a Partner in the law firm DLA Piper (US) Limited Liability Company. From 1982 until the formation of DLA Piper in 2005, he was an associate and then a Partner in the predecessor firms of DLA Piper, holding various management positions, including serving on its Board of Directors. Mr. Clowes currently serves on the board of Equalize Health. He serves as Director at D-Rev. Mr. Clowes served on the Board of the Law Foundation of Silicon Valley from 2008 until December 2018, serving during that period in positions including President of its Board of Directors, and Chair of a Strategic Planning and Chief Executive Officer Search Committee. Since 2017, Mr. Clowes has served as a Lecturer at U.C. Berkeley’s Berkeley School of Law, teaching a course in International Business Negotiations. Mr. Clowes concentrated his practice in the representation of public companies, venture finance, M&A and corporate collaborations. He has represented clients in the life sciences, semiconductor, networking, telecommunications and other industries. Prior to the merger of Gray Cary and DLA Piper, Mr. Clowes was the managing Partner of Gray Cary’s Transaction group, with responsibility for the operations of the Corporate/Securities, Intellectual Property, Tax and Real Estate groups. Mr. Clowes has been named a Northern California Super Lawyer in every year since 2005, as the result of a joint research project conducted by Law & Politics and San Francisco magazines. He has also been listed in The Best Lawyers in America. Mr. Clowes holds J.D., from University of California at Berkeley in 1982 and B.A., in Experimental Psychology from University of California at Santa Barbara in 1976.

Positions